What is the share price of Macleods Pharmaceuticals Ltd?

Company share prices are keep on changing according to the market conditions. The current trading price of Macleods Pharmaceuticals Ltd on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Macleods Pharmaceuticals?

The latest standalone P/E ratio of Macleods Pharmaceuticals as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Macleods Pharmaceuticals Ltd?

The latest standalone P/B ratio of Macleods Pharmaceuticals Ltd as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Macleods Pharmaceuticals Ltd?

The 52-week high of Macleods Pharmaceuticals Ltd is Rs. and the 52-week low is Rs. .

Macleods Pharmaceuticals Ltd Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Macleods Pharmaceuticals Ltd
Brand: Macleods Pharmaceuticals

Macleods Pharmaceuticals Ltd

Key Metrics

Valuation Multiples

Market Cap

₹0 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹19.5

TTM Sales

₹7,463 Cr.

Book Value per Share

₹90.4

P/E Ratio

0.00

Industry PE

46.5

Price to Book (P/B)

0.00

Price to Sales (P/S)

0.00

EV/EBITDA

0.00

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

22.58%

Return on Capital Employed (ROCE)

23.04%

Return on Assets (ROA)

17.54%

Operating Profit Margin

18.6%

Net Profit Margin

25.32%

Gross Profit Margin

27.9%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

4.7%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

5.28%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

11.25%

Asset Quality

Promoter Holding

100.00%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹5,353 Cr.

Equity

₹59.9 Cr.

Face Value

₹1

All Time Low / High

- / -

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	36.8%	34.1%	31.8%	36.5%	26.6%	26.3%	29.6%	44.1%	31.1%	23.6%	-
Value Creation Index ⓘ	1.6	1.4	1.3	1.6	0.9	0.9	1.1	2.2	1.2	0.7	-
Growth Parameters ⓘ
Sales ⓘ	2,821	3,469	4,042	5,134	5,506	6,076	6,591	7,014	7,463	7,813	7,463
Sales YoY Gr.	-	23%	16.5%	27%	7.2%	10.4%	8.5%	6.4%	6.4%	4.7%	-
Adj EPS ⓘ	7.2	9.1	10.6	15.9	17.4	20.8	29.8	33.3	18.5	24	19.5
YoY Gr.	-	26.4%	16.4%	50.2%	9.3%	19.8%	43%	11.9%	-44.5%	29.7%	-
BVPS (₹) ⓘ	27.9	36.5	46.1	62.4	82.1	104.8	135.1	70.9	90.4	115.2	90.4
Adj Net Profit ⓘ	432	545	635	953	1,042	1,248	1,784	1,995	1,108	1,437	1,167
Cash Flow from Ops. ⓘ	422	517	438	1,553	571	768	960	1,275	1,411	2,001	-
Debt/CF from Ops. ⓘ	0.2	0.3	0.4	0	0	0	0.1	0.1	0.1	0.1	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	12%	7.3%	5.8%	4.7%
Adj EPS ⓘ	14.3%	6.6%	-7%	29.7%
BVPSⓘ	17.1%	7%	-5.2%	27.5%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	29.6	28.3	25.6	29.3	24.1	22.3	24.8	32.3	22.9	23.3	19
Op. Profit Mgn % ⓘ	19.2	18.7	19.2	23.1	20.9	22.1	28.9	33.4	20.9	18.6	NAN
Net Profit Mgn % ⓘ	15.3	15.7	15.7	18.6	18.9	20.5	27.1	28.4	14.8	18.4	15.6
Debt to Equity ⓘ	0.1	0.1	0.1	0	0	0	0	0	0	0	-
Working Cap Days ⓘ	133	152	165	135	137	158	235	237	194	198	0
Cash Conv. Cycle ⓘ	54	39	35	29	32	47	54	73	100	82	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	4,042.46	5,134.44	5,505.51	6,076.16	6,590.50	7,014.11	7,462.67	7,813.30	8,373.18	8,991.37
Operating Expenses ⓘ +	3,268.54	3,948.68	4,352.50	4,736.76	4,686.17	4,670.54	5,903.28	6,381.99	6,239.62	6,745.19
Manufacturing Costs	335.46	334.08	494.67	608.20	252.76	398.54	439.47	434.36	427.46	489.65
Material Costs	1,727.32	2,141.62	2,308.30	2,520.51	2,193.24	2,179.30	2,806.08	2,919.51	2,853.03	2,951.20
Employee Cost	533.46	644.46	784.40	851.91	1,129.56	1,149.03	1,497.48	1,578.14	1,586.06	1,742.14
Other Costs ⓘ	672.30	828.53	765.12	756.14	1,110.62	943.67	1,160.26	1,449.98	1,373.07	1,562.20
Operating Profit ⓘ	773.92	1,185.75	1,153	1,339.40	1,904.32	2,343.56	1,559.38	1,431.31	2,133.56	2,246.18
Operating Profit Margin (%)	19.1%	23.1%	20.9%	22.0%	28.9%	33.4%	20.9%	18.3%	25.5%	25.0%
Other Income ⓘ +	117.96	106.86	78.78	223.12	329.95	544.64	125.82	213.34	499.41	316.74
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	7.75	5.79	4.33	8.27	19.15	5.84	10.81	7.43	11.61	8.54
Depreciation ⓘ	52.62	70.07	80.77	90.21	94.63	132.13	156.55	169.85	163.86	172.88
Profit Before Tax ⓘ	831.51	1,216.75	1,146.69	1,464.04	2,120.50	2,750.23	1,517.84	1,467.37	2,457.50	2,381.50
Tax ⓘ	185.24	259.83	77.58	182.32	265.26	533.91	350.61	-8.02	411.29	105.13
Profit After Tax	646.27	956.93	1,069.11	1,281.73	1,855.24	2,216.33	1,167.23	1,475.39	2,046.21	2,276.37
PAT Margin (%)	16.0%	18.6%	19.4%	21.1%	28.2%	31.6%	15.6%	18.9%	24.4%	25.3%
Adjusted EPS (₹)	10.8	16.0	17.9	21.4	31.0	37.0	19.5	24.6	31.5	35.1
Dividend Payout Ratio (%)	9.30%	0%	0%	1.60%	0%	0%	0%	0%	0%	0%

Valuation of Macleods Pharmaceuticals - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	2,761.39	3,737.70	4,914.64	6,277.33	8,092.69	4,246.65	5,413.26	6,900.18	8,941.92	11,221.96
Share Capital ⓘ	19.96	19.96	19.96	19.96	19.96	19.96	59.88	59.88	64.87	64.87
Reserves ⓘ	2,741.43	3,717.74	4,894.68	6,257.37	8,072.73	4,226.69	5,353.38	6,840.29	8,877.05	11,157.09
Debt +	185	7.68	7.68	0	67.89	79.72	78.15	127.28	256.21	325.22
Long Term Debt	7.68	7.68	7.68	0	31.82	0	0	0	0	0.04
Short Term Debt	177.31	0	0	0	36.07	79.72	78.15	127.28	256.21	325.18
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	498.16	782.18	655.44	492.29	690.02	522.88	536.69	592.31	467.44	537.38
Others Liabilities ⓘ	224.30	328.21	483.56	604.14	545.87	469.71	411.85	274.69	2,960.71	1,249.85
Total Liabilities ⓘ	3,668.84	4,855.77	6,061.34	7,373.77	9,396.47	5,318.96	6,439.94	7,894.45	12,626.28	13,334.41
Fixed Assets
Net Fixed Assets ⓘ +	878.91	1,064.10	1,063.23	1,074.44	1,245.48	1,399.64	1,473.42	1,618.99	1,627.62	1,766.33
Gross Block	1,127.01	1,379.70	1,455.08	1,549.14	1,804.50	2,250.05	2,462.40	2,716.03	2,869	3,159.61
Accumulated Depreciation	248.10	315.61	391.85	474.70	559.02	850.41	988.99	1,097.04	1,241.38	1,393.28
CWIP ⓘ	104.21	14.59	26.83	51.15	213.55	252.75	334.34	189.93	287.44	526.71
Investments ⓘ	10.09	1,321.37	2,355.24	1,424.40	1,841.04	16.93	252.31	1,885.65	3,391.02	4,985.18
Inventories	592.49	789.11	710.92	720.99	895.94	1,229.59	1,542.68	1,239.23	1,412.11	1,478.37
Trade Receivables	564.47	625.18	780.50	960.29	1,198.98	1,455.30	1,259.95	1,126.32	1,233.97	1,489.80
Cash Equivalents	757.27	585.25	328.59	1,843.60	585.08	27.79	17.75	47.11	73.73	34.22
Others Assets ⓘ	761.39	456.18	796.03	1,298.90	3,416.40	936.97	1,559.50	1,787.22	4,600.39	3,053.80
Total Assets ⓘ	3,668.84	4,855.77	6,061.34	7,373.77	9,396.47	5,318.96	6,439.94	7,894.45	12,626.28	13,334.41

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	437.52	1,553.12	570.56	768.25	960.18	1,275.39	1,411.25	2,001.06	1,190.28	1,757.75
PBT ⓘ	831.51	1,216.75	1,146.69	1,464.04	2,120.50	2,750.23	1,517.84	1,467.37	2,457.50	2,381.50
Adjustment ⓘ	-29.28	94.44	47.18	-97.81	-117.42	-343	113.05	98.35	-274.51	13.92
Changes in Working Capital ⓘ	-174.84	502.07	-374.86	-214.9	-690.96	-654.3	95.14	664.11	-651.53	-239.19
Tax Paid ⓘ	-189.86	-260.15	-248.46	-383.09	-351.93	-477.54	-314.77	-228.77	-341.18	-398.48
Cash Flow From Investing Activity ⓘ +	-111	-1,344.46	-839.01	-747.57	-661.95	-1,329.57	-1,399.59	-2,077.32	-1,267.83	-1,849.77
Capex	-301.70	-1,442.22	-102.35	-125.55	-445.86	-785.95	-273.20	-182.32	-290.17	-555.32
Net Investments	0	0	-893.72	1,035.79	-480.62	-914.75	-12.46	-222.63	-1,204.91	-1,557.29
Others ⓘ	190.70	97.76	157.06	-1,657.81	264.53	371.13	-1,113.92	-1,672.37	227.25	262.84
Cash Flow From Financing Activity ⓘ +	-45.37	-5.79	-4.33	-40.02	-115.51	30.46	-21.12	95.36	104.74	48.48
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	-7.68	0	0	0	0	0	0
Interest Paid ⓘ	-7.75	0	-4.33	-8.27	-16.68	-3.12	-8.35	4.95	-9.70	-5.50
Dividend Paid ⓘ	-72.07	0	0	-19.96	0	0	0	0	0	0
Others ⓘ	34.45	-5.79	0	-4.10	-98.84	33.58	-12.77	90.41	114.44	53.98
Net Cash Flow ⓘ	281.15	202.87	-272.78	-19.34	182.71	-23.72	-9.46	19.10	27.19	-43.54

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	26.12	29.45	24.71	22.9	25.82	35.92	24.17	23.96	25.83	22.58
ROCE (%)	31.77	36.54	26.56	26.29	29.64	44.14	31.14	23.56	30.43	23.04
Asset Turnover Ratio	1.22	1.2	1.01	0.91	0.79	0.95	1.27	1.09	0.83	0.71
PAT to CFO Conversion(x)	0.68	1.62	0.53	0.6	0.52	0.58	1.21	1.36	0.58	0.77
Working Capital Days
Receivable Days	41.30	42.30	46.40	52.30	59.80	69.10	66.40	55.70	50.60	54.30
Inventory Days	48.60	49.10	49.50	43	44.80	55.30	67.80	65	56.80	57.60
Payable Days	92.80	109.10	113.70	83.10	98.40	101.60	68.90	70.60	67.80	62.10

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Macleods Pharmaceuticals Ltd FAQs

The current trading price of Macleods Pharmaceuticals on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Macleods Pharmaceuticals stood at ₹0.00 Cr

The latest P/E ratio of Macleods Pharmaceuticals as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Macleods Pharmaceuticals as of 31-Dec-1969 is 0.00.

The 52-week high of Macleods Pharmaceuticals is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Macleods Pharmaceuticals is ₹7,463 ( Cr.) .

Data is not available for this company.

No data found

About Macleods Pharmaceuticals Ltd

No data to display

Macleods Pharmaceuticals Ltd

Macleods Pharmaceuticals Ltd

10 Year X-Ray :